Sibeprenlimab inches closer to approval
www.hcplive.com/view/fda-acc... feat @brendonneuen.bsky.social
Phase 3 RCT next week at #ERA25 (& some journal?)
With the priority review acceptance of the Biologics License Application, the FDA has assigned a PDUFA target action date of November 28, 2025.
